Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Genus plc ( (GB:GNS) ).
Genus plc announced a change in the voting rights of JNE Partners LLP, as 5.025031% of the voting rights were acquired, bringing the total to 3,318,273 shares. This acquisition reflects a significant stake in the company, indicating confidence in Genus’s market positioning and potential growth, which could impact stakeholder interests and the company’s future strategic decisions.
More about Genus plc
Genus plc is a UK-based company that operates in the agriculture and biotechnology industries, focusing primarily on animal genetics and breeding services. It aims to support farmers and agricultural businesses by enhancing livestock quality and productivity through its advanced genetic technologies.
YTD Price Performance: -22.96%
Average Trading Volume: 115,057
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £1.08B
For a thorough assessment of GNS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue